Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Epigenomic changes may either cause disease or modulate its expressivity, adding a layer of complexity to mendelian diseases. X‐linked adrenoleukodystrophy (X‐ALD) is a rare neurometabolic condition exhibiting discordant phenotypes, ranging from a childhood cerebral inflammatory demyelination (cALD) to an adult‐onset mild axonopathy in spinal cords (AMN). The AMN form may occur with superimposed inflammatory brain demyelination (cAMN). All patients harbor loss of function mutations in the ABCD1 peroxisomal transporter of very‐long chain fatty acids. The factors that account for the lack of genotype‐phenotype correlation, even within the same family, remain largely unknown. To gain insight into this matter, here we compared the genome‐wide DNA methylation profiles of morphologically intact frontal white matter areas of children affected by cALD with adult cAMN patients, including male controls in the same age group. We identified a common methylomic signature between the two phenotypes, comprising (i) hypermethylation of genes harboring the H3K27me3 mark at promoter regions, (ii) hypermethylation of genes with major roles in oligodendrocyte differentiation such as MBP , CNP , MOG and PLP1 and (iii) hypomethylation of immune‐associated genes such as IFITM1 and CD59 . Moreover, we found increased hypermethylation in CpGs of genes involved in oligodendrocyte differentiation, and also in genes with H3K27me3 marks in their promoter regions in cALD compared with cAMN, correlating with transcriptional and translational changes. Further, using a penalized logistic regression model, we identified the combined methylation levels of SPG20 , UNC45A and COL9A3 and also, the combined expression levels of ID4 and MYRF to be good markers capable of discriminating childhood from adult inflammatory phenotypes. We thus propose the hypothesis that an epigenetically controlled, altered transcriptional program may drive an impaired oligodendrocyte differentiation and aberrant immune activation in X‐ALD patients. These results shed light into disease pathomechanisms and uncover putative biomarkers of interest for prognosis and phenotypic stratification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Redox status, mitochondrial fitness and proteostasis capacities are affected during and may contribute to aging (46).”
BackgroundLinking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“DNA methylation and histone modification, particularly methylation of residue K27 in H3, may be interdependent (10).”
BackgroundDu, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136 · cited 2×
“For determining differential methylation, b-values were first converted to M-values via the logit transformation, as recommended by Du et al (13).”
MethodDNA-binding factors shape the mouse methylome at distal regulatory regions
Stadler, M. B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Schöler, A., Nimwegen, E. V., Wirbelauer, C., Oakeley, E. J., Gaidatzis, D., et al. (2011) · Nature · doi:10.1038/nature10716 · Cited by 1,383 · cited 1×
“The majority of both hypomethylated and hypermethylated CpGs revealed subtle changes within the range of modifications consistent with reported environment-gene interactions (32, 71).”
BackgroundPutative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 1×
“This disease is caused by mutations in the ABCD1 (ALD) gene (Xq28) encoding the peroxisomal ABC transporter (17, 53), which transports very-long-chain fatty acids (VLCFAs) or VLCFA–CoA esters into the peroxisome for degradation by β-oxidation (75).”
BackgroundValidation of a DNA methylation microarray for 450,000 CpG sites in the human genome
Sandoval, J., Heyn, H., Moran, S., Serra-Musach, J., Pujana, M. A., Bibikova, M., & Esteller, M. (2011) · Epigenetics · doi:10.4161/epi.6.6.16196 · Cited by 990 · cited 1×
“The 450K DNA methylation array by Illumina is an established, highly reproducible method for DNA methylation detection and has been validated (60).”
MethodSelf-citationVariations in DNA elucidate molecular networks that cause disease
Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S. K., et al. (2008) · Nature · doi:10.1038/nature06757 · Cited by 887 · cited 1×
“fusion protein in acute promyelocytic leukemia (APL) cell lines, on the basis of Chip-seq data (48), and in genes that form the macrophage-enriched metabolic network (MEMN) and have a causal relationship with metabolic syndrome traits (11) (Supporting Information Table S3).”
BackgroundUncovering the role of 5-hydroxymethylcytosine in the epigenome
Branco, M. R., Ficz, G., & Reik, W. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3080 · Cited by 766 · cited 1×
“The latter may also constitute a stable epigenetic modification shown to contribute regulatory functions to the epigenome (9).”
BackgroundEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · cited 1×
“Loss of myelin may be counteracted by the formation of new myelin by resident oligodendrocyte progenitors, which are spread out throughout the brain parenchyma and have the ability to differentiate into myelinating oligodendrocytes (23, 77).”
BackgroundX-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283 · cited 1×
“In contrast, AMN is a chronic, slowly progressive form and relapsing-remitting presentations are never seen, unlike in multiple sclerosis subtypes (35), or rarely, in other leukodystrophies such as metachromatic leukodystrophy (2).”
BackgroundThe human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233 · cited 1×
“This disease is caused by mutations in the ABCD1 (ALD) gene (Xq28) encoding the peroxisomal ABC transporter (17, 53), which transports very-longchain fatty acids (VLCFAs) or VLCFA–CoA esters into the peroxisome for degradation by b-oxidation (75).”
BackgroundEarly oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214
Self-citationIs microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?
Eichler, F. S., Ren, J., Cossoy, M., Rietsch, A. M., Nagpal, S., Moser, A. B., Frosch, M. P., & Ransohoff, R. M. (2008) · Annals of Neurology · doi:10.1002/ana.21391 · Cited by 178
Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148 · cited 2×
“Additionally, VLCFAs are incorporated into complex lipids within cell membranes and are thought to destabilize myelin sheaths by occupying the lateral chains of proteolipid proteins, gangliosides and phospholipids (8, 68).”
BackgroundSelf-citationRole of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141 · cited 1×
“There is ample evidence suggesting that epigenetic mechanisms may mediate the development of chronic inflammation by modulating the expression of proinflammatory cytokines such as TNF and interleukins and the autocrine and paracrine activation of the transcription factor NF-kB (63), which we have recently described as…”
BackgroundGeneral aspects and neuropathology of X-linked adrenoleukodystrophy
Ferrer, I., Aubourg, P., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00390.x · Cited by 139
Self-citationLópez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125 · cited 1×
“Excess VLCFA results in increased free radical production from mitochondria and altered cellular proteostasis (22, 38, 39, 45).”
BackgroundSelf-citationCerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype
Korenke, G. C., Wilichowski, E., Hunneman, D. H., Hanefeld, F., Fuchs, S., Krasemann, E., & Doerr, H. G. (1996) · Annals of Neurology · doi:10.1002/ana.410400221 · Cited by 117
Swiss, V. A., Nguyen, T., Dugas, J., Ibrahim, A., Barres, B., Androulakis, I. P., & Casaccia, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018088 · Cited by 112 · cited 1×
“This is a consequence of the recruitment of histone deacetylases (HDACs) and repressive histone methyl transferases, thus allowing the temporal downregulation of inhibitors followed by increased transcription of myelin genes (28, 73).”
BackgroundSelf-citationBergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94
Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., & Aubourg, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi140 · Cited by 86 · cited 1×
“Although disease severity may correlate with increased VLCFA content in the white matter (4), it remains to be determined whether excess VLCFAs may trigger cerebral inflammation and demyelination.”
BackgroundFunctional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
Schlüter, A., Espinosa, L., Fourcade, S., Galino, J., López, E., Ilieva, E., Morató, L., Asheuer, M., Cook, T., McLaren, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr536 · Cited by 72 · cited 6×
“There is ample evidence suggesting that epigenetic mechanisms may mediate the development of chronic inflammation by modulating the expression of proinflammatory cytokines such as TNF and interleukins and the autocrine and paracrine activation of the transcription factor NF-kB (63), which we have recently described as…”
BackgroundMethodInfluentialSelf-citationFatty Acid Composition of Human Myelin Proteolipid Protein in Peroxisomal Disorders
Bizzozero, O. A., Zuñiga, G., & Lees, M. B. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02003.x · Cited by 61
Stem cells, progenitors and myelin repair
Zhao, C., Fancy, S. P. J., Magy, L., Urwin, J. E., & Franklin, R. J. M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00456.x · Cited by 61 · cited 1×
“Loss of myelin may be counteracted by the formation of new myelin by resident oligodendrocyte progenitors, which are spread out throughout the brain parenchyma and have the ability to differentiate into myelinating oligodendrocytes (23, 77).”
BackgroundPhenotypic heterogeneity of an adult form of adrenoleukodystrophy in monozygotic twins
Sobue, G., Ueno‐Natsukari, I., Okamoto, H., Connell, T. A., Aizawa, I., Mizoguchi, K., Honma, M., Ishikawa, G., Mitsuma, T., & Natsukari, N. (1994) · Annals of Neurology · doi:10.1002/ana.410360617 · Cited by 56 · cited 1×
“Interestingly, all clinical phenotypes can occur within the same family and be even discordant in monozygotic twins (37, 70), illustrating a lack of phenotype–genotype correlation adding a layer of complexity to an in principle, monogenic disorder, and thus suggests the participation of modifying genetic factors, stoc…”
BackgroundFourcade, S., López-Erauskin, J., Ruiz, M., Ferrer, I., & Pujol, A. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.012 · Cited by 55
Self-citation
Cited by
Bergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94
“Further research aiming to identify the specific cascades leading to phagocyte death in early X-ALD is crucially needed as this may help understand yet unknown triggers of lesion development, and unravel the mystery of the lacking correlation of genotype and cerebral phenotype in the disease (Berger et al., 2010; Berg…”
BackgroundRodríguez-Pascau, L., Vilalta, A., Cerrada, M., Traver, E., Forss-Petter, S., Weinhofer, I., Bauer, J., Kemp, S., Pina, G., Pascual, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0555 · Cited by 40
Richmond, P. A., van der Kloet, F., Vaz, F. M., Lin, D., Uzozie, A., Graham, E., Kobor, M., Mostafavi, S., Moerland, P. D., Lange, P. F., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00520 · Cited by 29
Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy
Palakuzhiyil, S. V., Christopher, R., & Chandra, S. R. (2020) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v11.i3.99 · Cited by 24
Bergner, C. G., Genc, N., Hametner, S., Franz, J., van der Meer, F., Mitkovski, M., Weber, M. S., Stoltenburg‐Didinger, G., Kühl, J., Köhler, W., et al. (2021) · Glia · doi:10.1002/glia.24042 · Cited by 23
Metadata
- Authors
- Schlüter, A., Sandoval, J., Fourcade, S., Díaz‐Lagares, A., Ruiz, M., Casaccia, P., Esteller, M., & Pujol, A.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2018-04-10
- Volume
- 28
- Issue
- 6
- Pages
- 902-919
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2790993274
- Cited by
- 35
- References
- 26
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.